Understanding a decade of safety reporting for sacral neuromodulation in the Food and Drug Administration Manufacturer and User Facility Device Experience database.
PMID: 37497812 ·
C, a, i, t, l, i, n, , E, , C, a, r, l, t, o, n, ;, , C, o, l, b, y, , P, , S, o, u, d, e, r, s, ;, , N, a, t, h, a, n, , A, , C, h, e, r, t, a, c, k, ;, , R, a, m, y, , S, , G, o, u, e, l, i, ;, , G, a, r, y, , E, , L, e, m, a, c, k, ;, , J, e, n, n, i, f, e, r, , T, , A, n, g, e, r, ;, , L, y, n, n, , M, c, C, l, e, l, l, a, n, d, ;, , M, a, u, d, e, , E, , C, a, r, m, e, l
Anzeige
Zusammenfassung
Over 350 000 sacral neuromodulation (SNM) devices have been implanted since approval by the Food and Drug Administration (FDA) in 1998. SNM technology and clinical applications have evolved, with minimal safety updates after initial trials. We aim to provide an updated overview of real-world SNM safety. These insights will guide informed consent, preoperative counseling, and patient expectation-setting. The FDA Manufacturer and User Facility Device Experience (MAUDE) database is a repository for
Anzeige
Offizielle Quelle
Auf PubMed ansehen →Daten aus PubMed / NCBI. Den Volltext und die aktuellsten Informationen finden Sie stets im offiziellen Eintrag.